Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KERX
5101
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $326K | ﹤0.01% |
69,833
+3,362
| +5% | +$13.4K |
|
|
NLSN
5102
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $326K | ﹤0.01% |
6,200
-184,400
| -97% | -$8.92M |
|
|
YELL
5103
DELISTED
Yellow Corporation Common Stock
YELL
| $326K | ﹤0.01% |
34,926
+27,767
| +388% | +$263K |
|
5104
CALL
Amkor Technology
AMKR
$13.7B
| $325K | ﹤0.01% |
55,100
+27,700
| +101% | +$150K |
|
5105
First Trust US Equity Opportunities ETF
FPX
$1.51B
| $325K | ﹤0.01% |
6,499
-522
| -7% | -$24.7K |
|
5106
CALL
NRG Energy
NRG
$24.8B
| $325K | ﹤0.01% |
25,000
-197,300
| -89% | -$2.26M |
|
5107
PUT
Ally Financial
ALLY
$13.3B
| $324K | ﹤0.01% |
17,300
-376,100
| -96% | -$6.48M |
|
|
GDEN
5108
DELISTED
Golden Entertainment
GDEN
| $324K | ﹤0.01% |
+29,873
| New | +$304K |
|
5109
CALL
InterDigital
IDCC
$8.89B
| $323K | ﹤0.01% |
5,800
-1,300
| -18% | -$62.8K |
|
5110
Natural Gas Services Group
NGS
$477M
| $323K | ﹤0.01% |
14,953
+5,820
| +64% | +$111K |
|
|
XONE
5111
DELISTED
The ExOne Company
XONE
| $323K | ﹤0.01% |
24,553
-44,688
| -65% | -$426K |
|
5112
Clean Energy Fuels
CLNE
$346M
| $322K | ﹤0.01% |
109,755
-142,938
| -57% | -$402K |
|
5113
Western New England Bancorp
WNEB
$275M
| $322K | ﹤0.01% |
+38,166
| New | +$315K |
|
|
CUTR
5114
DELISTED
Cutera, Inc.
CUTR
| $322K | ﹤0.01% |
+28,580
| New | +$324K |
|
5115
Civeo
CVEO
$318M
| $321K | ﹤0.01% |
21,690
+5,628
| +35% | +$74.8K |
|
5116
Inovio Pharmaceuticals
INO
$69M
| $321K | ﹤0.01% |
3,069
+2,518
| +457% | +$194K |
|
|
LGTY
5117
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $320K | ﹤0.01% |
35,544
+24,089
| +210% | +$224K |
|
|
ABB
5118
PUT
DELISTED
ABB Ltd
ABB
| $320K | ﹤0.01% |
16,500
+11,300
| +217% | +$200K |
|
|
RLYP
5119
DELISTED
RELYPSA INC COM
RLYP
| $320K | ﹤0.01% |
23,580
-47,703
| -67% | -$811K |
|
5120
PUT
Becton Dickinson
BDX
$48.7B
| $319K | ﹤0.01% |
2,153
-2,870
| -57% | -$407K |
|
5121
Onto Innovation
ONTO
$15.3B
| $319K | ﹤0.01% |
+20,157
| New | +$282K |
|
5122
CALL
Unisys
UIS
$217M
| $319K | ﹤0.01% |
41,400
+23,800
| +135% | +$227K |
|
|
SPNC
5123
CALL
DELISTED
Spectranetics Corp
SPNC
| $319K | ﹤0.01% |
22,000
+8,100
| +58% | +$112K |
|
|
PWE
5124
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $319K | ﹤0.01% |
343,356
-109,560
| -24% | -$93.4K |
|
|
ABAX
5125
DELISTED
Abaxis Inc
ABAX
| $319K | ﹤0.01% |
7,036
-15,904
| -69% | -$707K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.